• 1.

    Nussenblatt RB (1990) The natural history of uveitis. Int Ophthalmol 14(5–6):303–308. https://doi.org/10.1007/BF00163549

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • 2.

    Suttorp-Schulten MS, Rothova A (1996) The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol 80(9):844–848. https://doi.org/10.1136/bjo.80.9.844

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 3.

    Dick AD, Tundia N, Sorg R, Zhao C, Chao J, Joshi A, Skup M (2016) Risk of ocular complications in patients with noninfectious intermediate Uveitis, posterior Uveitis, or Panuveitis. Ophthalmology 123(3):655–662. https://doi.org/10.1016/j.ophtha.2015.10.028

    Article 
    PubMed 

    Google Scholar
     

  • 4.

    Durrani OM, Tehrani NN, Marr JE, Moradi P, Stavrou P, Murray PI (2004) Degree, duration, and causes of visual loss in uveitis. Br J Ophthalmol 88(9):1159–1162. https://doi.org/10.1136/bjo.2003.037226

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 5.

    Tsirouki T, Dastiridou A, Symeonidis C, Tounakaki O, Brazitikou I, Kalogeropoulos C, Androudi S (2018) A focus on the epidemiology of Uveitis. Ocul Immunol Inflamm 26(1):2–16. https://doi.org/10.1080/09273948.2016.1196713

    Article 
    PubMed 

    Google Scholar
     

  • 6.

    Miserocchi E, Fogliato G, Modorati G, Bandello F (2013) Review on the worldwide epidemiology of uveitis. Eur J Ophthalmol 23(5):705–717. https://doi.org/10.5301/ejo.5000278

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 7.

    Jabs DA (2018) Immunosuppression for the Uveitides. Ophthalmology 125(2):193–202. https://doi.org/10.1016/j.ophtha.2017.08.007

    Article 
    PubMed 

    Google Scholar
     

  • 8.

    Koronis S, Stavrakas P, Balidis M, Kozeis N, Tranos PG (2019) Update in treatment of uveitic macular edema. Drug Des Devel Ther 13:667–680. https://doi.org/10.2147/DDDT.S166092

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 9.

    Tempest-Roe S, Joshi L, Dick AD, Taylor SRJ (2013) Local therapies for inflammatory eye disease in translation: past, present and future. BMC Ophthalmol 13(1):39. https://doi.org/10.1186/1471-2415-13-39

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 10.

    Sallam A, Taylor SRJ, Habot-Wilner Z, Elgohary M, Do HH, McCluskey P, Lightman S (2012) Repeat intravitreal triamcinolone acetonide injections in uveitic macular oedema. Acta Ophthalmol 90(4):e323–e325. https://doi.org/10.1111/j.1755-3768.2011.02247.x

    Article 
    PubMed 

    Google Scholar
     

  • 11.

    Leder HA, Jabs DA, Galor A, Dunn JP, Thorne JE (2011) Periocular triamcinolone acetonide injections for cystoid macular edema complicating noninfectious uveitis. Am J Ophthalmol 152(3):441–448 e2. https://doi.org/10.1016/j.ajo.2011.02.009

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • 12.

    Sen HN, Vitale S, Gangaputra SS, Nussenblatt RB, Liesegang TL, Levy-Clarke GA, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Kempen JH (2014) Periocular corticosteroid injections in uveitis: effects and complications. Ophthalmology 121(11):2275–2286. https://doi.org/10.1016/j.ophtha.2014.05.021

    Article 
    PubMed 

    Google Scholar
     

  • 13.

    Hunter RS, Lobo AM (2011) Dexamethasone intravitreal implant for the treatment of noninfectious uveitis. Clin Ophthalmol 5:1613–1621. https://doi.org/10.2147/OPTH.S17419

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 14.

    LeHoang P (2012) The gold standard of noninfectious uveitis: corticosteroids. Dev Ophthalmol 51:7–28. https://doi.org/10.1159/000336676

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • 15.

    Hoes JN, Jacobs JWG, Verstappen SMM, Bijlsma JWJ, van der Heijden GJMG (2009) Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis. Ann Rheum Dis 68(12):1833–1838. https://doi.org/10.1136/ard.2008.100008

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • 16.

    Steeples LR, Anand N, Moraji J, Jones NP (2018) Clinical outcomes of intravitreal preservative-free triamcinolone preparation (Triesence(R)) for cystoid macular Oedema and inflammation in patients with Uveitis. Ocul Immunol Inflamm 26(7):997–1004. https://doi.org/10.1080/09273948.2017.1294185

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • 17.

    Ganapathy PS, Lowder CY, Arepalli S, Baynes K, Li M, Bena J, Srivastava SK (2018) Treatment duration and side effect profile of long-term use of intravitreal preservative-free triamcinolone Acetonide in Uveitis. Am J Ophthalmol 194:63–71. https://doi.org/10.1016/j.ajo.2018.07.003

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • 18.

    Kok H et al (2005) Outcome of intravitreal triamcinolone in uveitis. Ophthalmology 112(11):1916 e1–1916 e7

    Article 

    Google Scholar
     

  • 19.

    Tanner V, Kanski JJ, Frith PA (1998) Posterior sub-Tenon’s triamcinolone injections in the treatment of uveitis. Eye (Lond) 12(Pt 4):679–685. https://doi.org/10.1038/eye.1998.168

    Article 

    Google Scholar
     

  • 20.

    Lowder C et al (2011) Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol 129(5):545–553. https://doi.org/10.1001/archophthalmol.2010.339

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 21.

    Taylor SR et al (2012) Dexamethasone implant in pediatric uveitis. Ophthalmology 119(11):2412.e2. https://doi.org/10.1016/j.ophtha.2012.07.025

    Article 

    Google Scholar
     

  • 22.

    Pavesio C et al (2010) Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis. Ophthalmology 117(3):567–575

    Article 
    PubMed 

    Google Scholar
     

  • 23.

    Callanan DG, Jaffe GJ, Martin DF, Pearson PA, Comstock TL (2008) Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results. Arch Ophthalmol 126(9):1191–1201. https://doi.org/10.1001/archopht.126.9.1191

    Article 
    PubMed 

    Google Scholar
     

  • 24.

    Jaffe GJ, Foster CS, Pavesio CE, Paggiarino DA, Riedel GE (2019) Effect of an injectable Fluocinolone Acetonide insert on recurrence rates in chronic noninfectious Uveitis affecting the posterior segment: twelve-month results. Ophthalmology 126(4):601–610. https://doi.org/10.1016/j.ophtha.2018.10.033

    Article 
    PubMed 

    Google Scholar
     

  • 25.

    Jaffe GJ, Lin P, Keenan RT, Ashton P, Skalak C, Stinnett SS (2016) Injectable Fluocinolone Acetonide long-acting implant for noninfectious intermediate Uveitis, posterior Uveitis, and Panuveitis: two-year results. Ophthalmology 123(9):1940–1948. https://doi.org/10.1016/j.ophtha.2016.05.025

    Article 
    PubMed 

    Google Scholar
     

  • 26.

    Dick AD, Rosenbaum JT, al-Dhibi HA, Belfort R Jr, Brézin AP, Chee SP, Davis JL, Ramanan AV, Sonoda KH, Carreño E, Nascimento H, Salah S, Salek S, Siak J, Steeples L, Accorinti M, Acharya N, Adan A, Agrawal R, Akkoc N, al Ghamdi S, al Ghamdi T, al Saati A, Alsabaani N, al-Shamarani M, Bachta A, Barisani-Asenbauer T, Beare N, Porto FBO, Blanco R, Yee ACS, Chandran V, Chiquet C, Chng HH, Cimbalas A, Cimino L, Cordero-Coma M, Cristobal C, Cuevas M, Eurico da Fonseca J, de Boer J, de la Torre A, de Schryver I, Derzko-Dzulynsky L, Diaz-Valle D, Merino CED, Facsko A, Figueira L, Fonollosa A, Fortin E, Gale R, Galeazzi M, Garcia S, Garcia Ruiz de Morales JM, Gašperšič N, Goldstein D, Guedes M, Guex-Crosier Y, Gul A, Hamam R, Haroon M, Hasegawa K, Heiligenhaus A, Hooper C, Hwang YS, Hwang DK, Juanola X, Kaburaki T, Kadayifcilar S, Kempen J, Kezuka T, Kherani A, Kirsimäe M, Kotaniemi K, Kraut A, Kubicka-Trząska A, Kuffova L, Lightman S, Lim L, Lim WK, McCluskey P, McGuire M, Mirabelli P, Miserocchi E, Misiuk-Hojło M, Muccioli C, Muñoz S, Murphy C, Murray PI, Nagy Z, Namba K, Neri P, Nguyen Q, O’Gradaigh D, Omair M, Otsa K, Ozyazgan Y, Pablo F, Paroli MP, Pleyer U, Poór G, Proença R, Rabinovitch T, Read R, Rebrov M, Recillas-Gispert C, Rothova A, Schwartzman S, Seve P, Sharma S, Sims J, Sohár N, Suhler E, Szántó S, Szepessy Z, Tappeiner C, Thorne J, Tugal Tutkun I, Turno-Kręcicka A, van Calster J, van der Horst-Bruinsma I, Vidovič Valentinčič N, Vitale A, Voorduin Ramos S, Vukojevic N, Wakefield D, Willermain F, Yalcindag N, Yamamoto JH, Yeh S, Zemaitiene R, Ziouzina O (2018) Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious Uveitis: fundamentals of care for UveitiS (FOCUS) initiative. Ophthalmology 125(5):757–773. https://doi.org/10.1016/j.ophtha.2017.11.017

    Article 
    PubMed 

    Google Scholar
     

  • 27.

    Esterberg E, Acharya NR (2012) Corticosteroid-sparing therapy: practice patterns among uveitis specialists. J Ophthalmic Inflamm Infect. 2(1):21–28. https://doi.org/10.1007/s12348-011-0047-5

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • 28.

    Nguyen QD, Hatef E, Kayen B, Macahilig CP, Ibrahim M, Wang J, Shaikh O, Bodaghi B (2011) A cross-sectional study of the current treatment patterns in noninfectious uveitis among specialists in the United States. Ophthalmology 118(1):184–190. https://doi.org/10.1016/j.ophtha.2010.03.029

    Article 
    PubMed 

    Google Scholar
     

  • 29.

    Thorne JE, Sugar EA, Holbrook JT, Burke AE, Altaweel MM, Vitale AT, Acharya NR, Kempen JH, Jabs DA, Multicenter Uveitis Steroid Treatment Trial Research Group (2019) Periocular triamcinolone vs. intravitreal triamcinolone vs. intravitreal dexamethasone implant for the Treatment of Uveitic macular edema: the PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) trial. Ophthalmology 126(2):283–295. https://doi.org/10.1016/j.ophtha.2018.08.021

    Article 
    PubMed 

    Google Scholar
     

  • 30.

    Roth DB, Verma V, Realini T, Prenner JL, Feuer WJ, Fechtner RD (2009) Long-term incidence and timing of intraocular hypertension after intravitreal triamcinolone acetonide injection. Ophthalmology 116(3):455–460. https://doi.org/10.1016/j.ophtha.2008.10.002

    Article 
    PubMed 

    Google Scholar
     

  • 31.

    Hirano Y, Ito T, Nozaki M, Yasukawa T, Sakurai E, Yoshida M, Ogura Y (2009) Intraocular pressure elevation following triamcinolone acetonide administration as related to administration routes. Jpn J Ophthalmol 53(5):519–522. https://doi.org/10.1007/s10384-009-0692-5

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • 32.

    Wang LC, Yang CM (2005) Sterile endophthalmitis following intravitreal injection of triamcinolone acetonide. Ocul Immunol Inflamm 13(4):295–300. https://doi.org/10.1080/09273940590951007

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • 33.

    Nelson ML et al (2003) Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina 23(5):686–691. https://doi.org/10.1097/00006982-200310000-00014

    Article 
    PubMed 

    Google Scholar
     

  • 34.

    U.S. Food and Drug Administration. Drug Approval Package: Yutiq. 2018. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/210331Orig1s000Approv.pdf. Accessed 15 May 2020

  • 35.

    Writing Committee for the Multicenter Uveitis Steroid Treatment, T et al (2017) Association between long-lasting Intravitreous Fluocinolone Acetonide implant vs systemic anti-inflammatory therapy and visual acuity at 7 years among patients with intermediate, posterior, or Panuveitis. JAMA 317(19):1993–2005

    Article 

    Google Scholar
     

  • 36.

    Jabs DA, Rosenbaum JT, Foster CS, Holland GN, Jaffe GJ, Louie JS, Nussenblatt RB, Stiehm ER, Tessler H, van Gelder RN, Whitcup SM, Yocum D (2000) Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 130(4):492–513. https://doi.org/10.1016/S0002-9394(00)00659-0

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • 37.

    Takeuchi M, Kanda T, Kaburaki T, Tanaka R, Namba K, Kamoi K, Maruyama K, Shibuya E, Mizuki N (2019) Real-world evidence of treatment for relapse of noninfectious uveitis in tertiary centers in Japan: a multicenter study. Medicine (Baltimore) 98(9):e14668. https://doi.org/10.1097/MD.0000000000014668

    CAS 
    Article 

    Google Scholar
     

  • 38.

    Barry RJ, Nguyen QD, Lee RW, Murray PI, Denniston AK (2014) Pharmacotherapy for uveitis: current management and emerging therapy. Clin Ophthalmol 8:1891–1911. https://doi.org/10.2147/OPTH.S47778

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 39.

    Carpentier SJ, Jung JL, Patnaik JL, Pecen PE, Palestine AG (2020) A cross-sectional online survey identifies subspecialty differences in the Management of Pediatric Cataracts Associated with Uveitis. Ophthalmol Ther 9(2):293–303. https://doi.org/10.1007/s40123-020-00245-x

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 40.

    Solebo AL, Rahi JS, Dick AD, Ramanan AV, Ashworth J, Edelsten C, Members of the POIG Uveitis Delphi Group (2020) Areas of agreement in the management of childhood non-infectious chronic anterior uveitis in the UK. Br J Ophthalmol 104(1):11–16. https://doi.org/10.1136/bjophthalmol-2018-313789

    Article 
    PubMed 

    Google Scholar
     

  • 41.

    Patel CC, Mandava N, Oliver SCN, Braverman R, Quiroz-Mercado H, Olson JL (2012) Treatment of intractable posterior uveitis in pediatric patients with the fluocinolone acetonide intravitreal implant (Retisert). Retina 32(3):537–542. https://doi.org/10.1097/IAE.0b013e31822058bb

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • 42.

    Sen HN, Grange L, Akanda M, Fox A (2017) Autoimmune retinopathy: current concepts and practices (an American ophthalmological society thesis). Trans Am Ophthalmol Soc 115:T8

    PubMed 

    Google Scholar
     

  • 43.

    Ozzello DJ, Palestine AG (2015) Factors affecting therapeutic decisions in intermediate and posterior uveitis. Am J Ophthalmol 159(2):213–220 e3. https://doi.org/10.1016/j.ajo.2014.10.015

    Article 
    PubMed 

    Google Scholar
     

  • 44.

    Burkholder BM, Moradi A, Thorne JE, Dunn JP (2015) The dexamethasone intravitreal implant for noninfectious Uveitis: practice patterns among Uveitis specialists. Ocul Immunol Inflamm 23(6):444–453. https://doi.org/10.3109/09273948.2015.1070180

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • 45.

    Palestine AG, Singh JK, Kolfenbach JR, Ozzello DJ (2016) Specialty practice and cost considerations in the Management of Uveitis Associated with Juvenile Idiopathic Arthritis. J Pediatr Ophthalmol Strabismus 53(4):246–251. https://doi.org/10.3928/01913913-20160505-01

    Article 
    PubMed 

    Google Scholar
     

  • 46.

    Cunningham ET Jr (2012) Surveying Uveitis specialists – a call for consensus. J Ophthalmic Inflamm Infect 2(2):61–63. https://doi.org/10.1007/s12348-012-0061-2

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Rights and permissions

    Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

    Disclaimer:

    This article is autogenerated using RSS feeds and has not been created or edited by OA JF.

    Click here for Source link (https://www.springeropen.com/)